Non-Inferiority Trial of TrIGR for PTSD Shows Promise Against Standard Therapy
A non-inferiority trial is underway to compare Trauma Informed Guilt Reduction Therapy (TrIGR) with cognitive processing therapy (CPT) for PTSD treatment in Veterans.
Phase III
Psychiatry / PTSD
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
Portfolio teams should consider the potential for TrIGR to disrupt existing PTSD treatment paradigms and evaluate its integration into their strategies.
Why it matters
The ongoing non-inferiority trial of TrIGR against CPT for PTSD treatment could significantly alter the landscape of PTSD therapies, particularly for Veterans. If successful, TrIGR may provide a more efficient treatment option, prompting a reevaluation of current therapeutic strategies in the field.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results for efficacy comparisons and any shifts in treatment guidelines based on findings.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.